EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR

Delisted

EUCR was delisted on the 26th of April, 2023.

Back to rankings

34 hedge funds and large institutions have $49.6M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$783K
2
+$768K
3
+$650K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$534K
5
BCM
Basso Capital Management
Connecticut
+$325K

Top Sellers

1
-$985K
2
-$103K
3
-$98K
4
SC
Shay Capital
New York
-$69.9K
5
WAM
Wolverine Asset Management
Illinois
-$50.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$263K
27
$206K
28
$199K
29
$118K
30
$103K
31
$38K
32
$24K
33
$11K
34
$489
35
–
36
–
37
–
1
2